Drugs / FOL100
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05611593 | Oct 2022 → Dec 2024 | androgenetic alopecia | Follicle Pharma Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FOL100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05611593 ↗ |
| Route | Topical | “apply FOL100 lotion topically” NCT05611593 ↗ |